ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group

March 21, 1997

NCI Plans To Expand CTSU Management Of Clinical Trials.

February 24, 2006

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Reagan’s 1983 Budget Would Fund NCI Grants to 180 Payline, 26 Percent Of Approved; Indirect Costs Cut

March 5, 1982

Doctor-Patient Interaction May Cause Racial Disparity

February 24, 2006

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002